| |
|
|
|
Adial Pharmaceuticals Inc.  
|
|
2.3 0.14 (0.06%) |
05-23 16:00 |
|
Open: |
2.2 |
Pre close: |
2.16 |
Target:
|
3.16
|
|
High: |
2.37 |
Low: |
2.2 |
Resistance:
|
2.71
3.13
|
|
Volume: |
44,920 |
Market Cap: |
23M |
Support:
|
2.02
1.68
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.21
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
2.48  |
Signal(12,26,9): |
-0.18 |
|
MA(100): |
3.97 |
Stochastic Oscillator |
%K(14,3):
|
16.52 |
|
MA(250): |
0.00 |
%D(3): |
11.58 |
|
Average Volume(K) |
3-Month: |
20358
|
52-Week |
High:
|
9.44 |
|
10-Days: |
5053 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
38.57 |
Change(%): |
-43.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-675.5 |
Shares Out. (M) |
10.22 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-491.4 |
Shares Float (M) |
8.93 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
19.80 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.50 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.960 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.17 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-2.50 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.64 |
P/CF |
-9.40 |
|
|
|
|
|
|
